SPECT/CT

Journal of Nuclear Medicine

Volumn 49, Issue 8, 2008, Pages 1305-1319

  Buck, Andreas K ^a   Nekolla, Stephan ^a   Ziegler, Sibylle ^a   Beer, Ambros ^a   Krause, Bernd J ^a   Herrmann, Ken ^a   Scheidhauer, Klemens ^a   Wester, Hans Juergen ^a   Rummeny, Ernst J ^a   Schwaiger, Markus ^a   Drzezga, Alexander ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CT; Hybrid imaging; PET; Scintigraphy; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3,4 DIHYDROXYPHENYLALANINE F 18; CIPROFLOXACIN TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IBRITUMOMAB TIUXETAN; IODINE 123; IODINE 131; IODOBENZAMIDE I 123; METAHYDROXYEPHEDRINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OXIDRONATE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; SELENOCHOLESTEROL SE 75; UNCLASSIFIED DRUG;

ALGORITHM; BRACHYTHERAPY; CANCER DIAGNOSIS; CARDIOLOGY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOSIMETRY; HUMAN; HYDROGEN BREATH TEST; IMAGE QUALITY; INTERMETHOD COMPARISON; LUNG CANCER; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; NEUROECTODERM TUMOR; NEUROENDOCRINE TUMOR; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PARAGANGLIOMA; PARATHYROID TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SCINTILLATION CAMERA; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER; THYROID CARCINOMA;

BONE DISEASES; FEMALE; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; MENTAL DISORDERS; NEOPLASMS; NERVOUS SYSTEM DISEASES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48749096862     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.050195     Document Type: Review

References (107)

1. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48(suppl 1):78S-88S.
2. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology. 2006;238:405-422.
3. O'Connor MK, Kemp BJ. Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med. 2006;36:258-266.
4. Perault C, Schvartz C, Wampach H, Liehn JC, Delisle MJ. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. J Nucl Med. 1997;38:1234-1242.
5. Frank A, Lefkowitz D, Jaeger S, et al. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys. 1995;32:1495-1512.
6. Forster GJ, Laumann C, Nickel O, Kann P, Rieker O, Bartenstein P. SPET/CT image co-registration in the abdomen with a simple and cost-effective tool. Eur J Nucl Med Mol Imaging. 2003;30:32-39.
7. Hasegawa BH, Wong KH, Iwata K, et al. Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat. 2002;1:449-458.
8. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med. 2000;27:619-627.
9. Xia W, Lewitt RM, Edholm PR. Fourier correction for spatially variant collimator blurring in SPECT. IEEE Trans Med Imaging. 1995;14:100-115.
10. Chen J, Caputlu-Wilson SF, Shi H, Galt JR, Faber TL, Garcia EV. Automated quality control of emission-transmission misalignment for attenuation correction in myocardial perfusion imaging with SPECT-CT systems. J Nucl Cardiol. 2006;13:43-49.
11. Kuehl H, Veit P, Rosenbaum SJ, Bockisch A, Antoch G. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. J Nucl Med. 2007;48(suppl 1):45S-57S.
12. Even-Sapir E, Lerman H, Lievshitz G, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med. 2003;44:1413-1420.
13. Zhang WJ, Zheng R, Wu LY, Li XG, Li B, Chen SZ. Clinical application of sentinel lymph node detection to early stage cervical cancer [in Chinese]. Ai Zheng. 2006;25:224-228.
14. Sherif A, Garske U, de la Torre M, Thorn M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol. 2006;50:83-91.
15. Khafif A, Schneebaum S, Fliss DM, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck. 2006;28:874-879.
16. Bilde A, Von Buchwald C, Mortensen J, et al. The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer. Acta Otolaryngol. 2006;126:1096-1103.
17. Keski-Santti H, Matzke S, Kauppinen T, Tornwall J, Atula T. Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2006;263:1008-1012.
18. Wagner A, Schicho K, Glaser C, et al. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma. J Craniomaxillofac Surg. 2004;32:343-349.
19. Husarik DB, Steinert HC. Single-photon emission computed tomography/computed tomography for sentinel node mapping in breast cancer. Semin Nucl Med. 2007;37:29-33.
20. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging. 2006;33:329-337.
21. Gallowitsch HJ, Kraschl P, Igerc I, et al. Sentinel node SPECT-CT in breast cancer: can we expect any additional and clinically relevant information? Nuklearmedizin. 2007;46:252-256.
22. van der Ploeg IM, Valdes Olmos RA, Nieweg OE, Rutgers EJ, Kroon BB, Hoefnagel CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007;48:1756-1760.
23. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007;48:201-206.
24. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942-2953.
25. Minoves M. Bone and joint sports injuries: the role of bone scintigraphy. Nucl Med Commun. 2003;24:3-10.
26. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46:1356-1367.
27. Römer W, Nomayr A, Uder M, Bautz W, Kuwert T. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med. 2006;47:1102-1106.
28. Seo Y, Wong KH, Sun M, Franc BL, Hawkins RA, Hasegawa BH. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. J Nucl Med. 2005;46:868-877.
29. Römer W, Reichel N, Vija HA, et al. Isotropic reconstruction of SPECT data using OSEM3D: correlation with CT. Acad Radiol. 2006;13:496-502.
30. Horger M, Eschmann SM, Pfannenberg C, et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR. 2004;183:655-661.
31. Utsunomiya D, Shiraishi S, Imuta M, et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology. 2006;238:264-271.
32. Even-Sapir E, Flusser G, Lerman H, Lievshitz G, Metser U. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med. 2007;48:319-324.
33. 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587-594.
34. 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908-1913.
35. Horger M, Eschmann SM, Pfannenberg C, et al. Added value of SPECT/CT in patients suspected of having bone infection: preliminary results. Arch Orthop Trauma Surg. 2007;127:211-221.
36. Ingui CJ, Shah NP, Oates ME. Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis. J Comput Assist Tomogr. 2007;31:375-380.
37. Nathan J, Crawford JA, Sodee DB, Bakale G. Fused SPECT/CT imaging of peri-iliopsoas infection using indium-111-labeled leukocytes. Clin Nucl Med. 2006;31:801-802.
38. Palestro CJ, Love C, Miller TT. Diagnostic imaging tests and microbial infections. Cell Microbiol. 2007;9:2323-2333.
39. Roach PJ, Schembri GP, Ho Shon IA, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl Med Commun. 2006;27:977-987.
40. 111mIn-DTPA SPECT-CT cisternography. Eur J Nucl Med Mol Imaging. 2006;33:856.
41. Ingui CJ, Shah NP, Oates ME. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med. 2006;31:665-672.
42. 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:1435-1442.
43. 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med. 2003;44:1905-1910.
44. Ruf J, Lehmkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun. 2004;25:1177-1182.
45. 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084-1089.
46. Harris L, Yoo J, Driedger A, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck. 2008;30:509-517.
47. Ruf J, Seehofer D, Denecke T, et al. Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin. 2007;46:15-21.
48. 99mTc- sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46:248-252.
49. Krausz Y, Bettman L, Guralnik L, et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2006;30:76-83.
50. Avram AM, Fig LM, Gross MD. Adrenal gland scintigraphy. Semin Nucl Med. 2006;36:212-227.
51. Gross MD, Avram A, Fig LM, Rubello D. Contemporary adrenal scintigraphy. Eur J Nucl Med Mol Imaging. 2007;34:547-557.
52. 123I-MIBG SPECT/CT. J Nucl Med. 2006;47:1635-1642.
53. Even-Sapir E, Keidar Z, Sachs J, et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med. 2001;42:998-1004.
54. 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf). 2003;59:565-573.
55. Hillel PG, van Beek EJ, Taylor C, et al. The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol. 2006;61:579-587.
56. 99mTc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours. Eur J Nucl Med Mol Imaging. 2005;32:1440-1451.
57. 2006 Image of the year: focus on cardiac SPECT/CT. J Nucl Med. 2006;47:14N-15N.
58. Berman DS, Hachamovitch R, Shaw LJ, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. J Nucl Med. 2006;47:74-82.
59. Berman DS, Shaw LJ, Hachamovitch R, et al. Comparative use of radionuclide stress testing, coronary artery calcium scanning, and noninvasive coronary angiography for diagnostic and prognostic cardiac assessment. Semin Nucl Med. 2007;37:2-16.
60. Raggi P, Berman DS. Computed tomography coronary calcium screening and myocardial perfusion imaging. J Nucl Cardiol. 2005;12:96-103.
61. Dondi M, Fagioli G, Salgarello M, Zoboli S, Nanni C, Cidda C. Myocardial SPECT: what do we gain from attenuation correction (and when)? Q J Nucl Med Mol Imaging. 2004;48:181-187.
62. Masood Y, Liu YH, Depuey G, et al. Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol. 2005;12:676-686.
63. Madsen MT. Recent advances in SPECT imaging. J Nucl Med. 2007;48:661-673.
64. Souvatzoglou M, Bengel F, Busch R, et al. Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET. Eur J Nucl Med Mol Imaging. 2007;34:1991-2000.
65. Koepfli P, Hany TF, Wyss CA, et al. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med. 2004;45:537-542.
66. Preuss R, Weise R, Lindner O, Fricke E, Fricke H, Burchert W. Optimisation of protocol for low dose CT-derived attenuation correction in myocardial perfusion SPECT imaging. Eur J Nucl Med Mol Imaging. 2008;35:1133-1141.
67. Martinez-Moller A, Souvatzoglou M, Navab N, Schwaiger M, Nekolla SG. Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions. J Nucl Med. 2007;48:188-193.
68. Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections. J Nucl Med. 2007;48:1112-1121.
69. Goetze S, Brown TL, Lavely WC, Zhang Z, Bengel FM. Attenuation correction in myocardial perfusion SPECT/CT: effects of misregistration and value of reregistration. J Nucl Med. 2007;48:1090-1095.
70. Goetze S, Wahl RL. Prevalence of misregistration between SPECT and CT for attenuation-corrected myocardial perfusion SPECT. J Nucl Cardiol. 2007;14:200-206.
71. McQuaid SJ, Hutton BF. Sources of attenuation-correction artefacts in cardiac PET/CT and SPECT/CT. Eur J Nucl Med Mol Imaging. 2008;35:1117-1123.
72. Guetter C, Wacker M, Xu C, Hornegger J. Registration of cardiac SPECT/CT data through weighted intensity co-occurrence priors. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 2007;10:725-733.
73. Kovalski G, Israel O, Keidar Z, Frenkel A, Sachs J, Azhari H. Correction of heart motion due to respiration in clinical myocardial perfusion SPECT scans using respiratory gating. J Nucl Med. 2007;48:630-636.
74. Onuma Y, Tanabe K, Nakazawa G, et al. Noncardiac findings in cardiac imaging with multidetector computed tomography. J Am Coll Cardiol. 2006;48:402-406.
75. Schietinger BJ, Bozlar U, Hagspiel KD, et al. The prevalence of extracardiac findings by multidetector computed tomography before atrial fibrillation ablation. Am Heart J. 2008;155:254-259.
76. Ballok ZE. Nuclear cardiology. Heart Lung Circ. 2005;14(suppl 2):S27-S30.
77. Slomka PJ, Berman DS, Germano G. Applications and software techniques for integrated cardiac multimodality imaging. Expert Rev Cardiovasc Ther. 2008;6:27-41.
78. Kalki K, Blankespoor SC, Brown JK, et al. Myocardial perfusion imaging with a combined x-ray CT and SPECT system. J Nucl Med. 1997;38:1535-1540.
79. 99mTc-sestamibi with SPECT: experimental validation in a porcine model. J Nucl Med. 2001;42:772-779.
80. Storto G, Sorrentino AR, Pellegrino T, Liuzzi R, Petretta M, Cuocolo A. Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries. Eur J Nucl Med Mol Imaging. 2007;34:1156-1161.
81. Storto G, Cirillo P, Vicario ML, et al. Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique. J Nucl Cardiol. 2004;11:682-688.
82. Lodge MA, Bengel FM. Methodology for quantifying absolute myocardial perfusion with PET and SPECT. Curr Cardiol Rep. 2007;9:121-128.
83. Esteves FP, Sanyal R, Santana CA, Shaw L, Raggi P. Potential impact of noncontrast computed tomography as gatekeeper for myocardial perfusion positron emission tomography in patients admitted to the chest pain unit. Am J Cardiol. 2008;101:149-152.
84. Henneman MM, Schuijf JD, Dibbets-Schneider P, et al. Comparison of multislice computed tomography to gated single-photon emission computed tomography for imaging of healed myocardial infarcts. Am J Cardiol. 2008;101:144-148.
85. Namdar M, Hany TF, Koepfli P, et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J Nucl Med. 2005;46:930-935.
86. Ghersin E, Keidar Z, Rispler S, et al. Images in cardiovascular medicine: hybrid cardiac single photon emission computed tomography/computed tomography imaging with myocardial perfusion single photon emission computed tomography and multidetector computed tomography coronary angiography for the assessment of unstable angina pectoris after coronary artery bypass grafting. Circulation. 2006;114:e237-e239.
87. Rispler S, Keidar Z, Ghersin E, et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol. 2007;49:1059-1067.
88. Gaemperli O, Schepis T, Kalff V, et al. Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imaging. 2007;34:1097-1106.
89. Gaemperli O, Schepis T, Valenta I, et al. Cardiac image fusion from stand-alone SPECT and CT: clinical experience. J Nucl Med. 2007;48:696-703.
90. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
91. Mahnken AH, Koos R, Katoh M, et al. Sixteen-slice spiral CT versus MR imaging for the assessment of left ventricular function in acute myocardial infarction. Eur Radiol. 2005;15:714-720.
92. Lardo AC, Cordeiro MA, Silva C, et al. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006;113:394-404.
93. Picano E. Economic and biological costs of cardiac imaging. Cardiovasc Ultrasound. 2005;3:13.
94. Wijns W. Anatomic-functional imaging by single-photon emission computed tomography/computed tomography as the cornerstone of diagnosis and treatment for coronary patients: a glimpse into the (near) future? J Am Coll Cardiol. 2007;49:1068-1070.
95. Chang L. A method for attenuation correction in radio-nuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
96. Hayashi M, Deguchi J, Utsunomiya K, et al. Comparison of methods of attenuation and scatter correction in brain perfusion SPECT. J Nucl Med Technol. 2005;33:224-229.
97. Van Laere K, Koole M, D'Asseler Y, et al. Automated stereotactic standardization of brain SPECT receptor data using single-photon transmission images. J Nucl Med. 2001;42:361-375.
98. Sulkin TV, Cousens C. SPECTCT cerebral perfusion scintigraphy; is the low-dose CT component of diagnostic value? Clin Radiol. 2008;63:289-298.
99. 131I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging. 2005;32:458-469.
100. 131I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes. J Nucl Med. 2004;45:1059-1064.
101. Thierens HM, Monsieurs MA, Bacher K. Patient dosimetry in radionuclide therapy: the whys and the wherefores. Nucl Med Commun. 2005;26:593-599.
102. 90Y-ibritumomab tiuxetan: comparative dosimetric study for tailored treatment. J Nucl Med. 2007;48:1871-1879.
103. 90Y-ibritumomab tiuxetan radioimmunotherapy of patients with non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 2008;23:53-64.
104. Prideaux AR, Song H, Hobbs RF, et al. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry. J Nucl Med. 2007;48:1008-1016.
105. Flux G, Bardies M, Monsieurs M, Savolainen S, Strands SE, Lassmann M. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy. Z Med Phys. 2006;16:47-59.
106. Ellis RJ, Kaminsky DA. Fused radioimmunoscintigraphy for treatment planning. Rev Urol. 2006;8(suppl 1):S11-S19.
107. Sodee DB, Sodee AE, Bakale G. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med. 2007;37:17-28.